Abstract
A lyophilization method was developed to locally release adenoviral vectors directly from biomaterials for in situ regenerative gene therapy. Adenovirus expressing a β-galactosidase reporter gene (AdLacZ) was mixed with different excipient formulations and lyophilized on hydroxyapatite (HA) disks followed by fibroblasts culturing and 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) staining, suggesting 1 M sucrose in phosphate-buffered saline had best viability. Adenovirus release studies showed that greater than 30% virus remained on the material surface up to 16 h. Lyophilized adenovirus could be precisely localized in defined patterns and the transduction efficiency was also improved. To determine if the lyophilization formulations could preserve viral bioactivity, the lyophilized AdLacZ was tested after being stored at varying temperatures. Bioactivity of adenovirus lyophilized on HA was maintained for greater than 6 months when stored at −80°C. In vivo studies were performed using an adenovirus encoding BMP-2 (AdBMP-2). AdBMP-2 was lyophilized in gelatin sponges and placed into rat critical-size calvarial defects for 5 weeks. Micro-computed tomography (μ-CT) analysis demonstrated that free-form delivery of AdBMP-2 had only modest effects on bone formation. In contrast, AdBMP-2 lyophilized in gelatin sponges led to more than 80% regeneration of critical-size calvarial defects.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lutolf MP, Weber FE, Schmoekel HG, Schense JC, Kohler T, Muller R et al. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol 2003; 21: 513–518.
Sheridan MH, Shea LD, Peters MC, Mooney DJ . Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release 2000; 64: 91–102.
Tabata Y . Tissue regeneration based on growth factor release. Tissue Eng 2003; 9 (Suppl): S5–S15.
Boyne PJ, Marx RE, Nevins M, Triplett G, Lazaro E, Lilly LC et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 1997; 17: 11–25.
Howell TH, Fiorellini J, Jones A, Alder M, Nummikoski P, Lazaro M et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent 1997; 17: 124–139.
Fang J, Zhu YY, Smiley E, Bonadio J, Rouleau JP, Goldstein SA et al. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA 1996; 93: 5753–5758.
Hannallah D, Peterson B, Lieberman JR, Fu FH, Huard J . Gene therapy in orthopaedic surgery. J Bone Joint Surg–Am Vol 2002; 84A: 1046–1061.
Franceschi RT . Biological approaches to bone regeneration by gene therapy. J Dent Res 2005; 84: 1093–1103.
Selkirk SM . Gene therapy in clinical medicine. Postgrad Med J 2004; 80: 560–570.
Ito H, Koefoed M, Tiyapatanaputi P, Gromov K, Goater JJ, Carmouche J et al. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med 2005; 11: 291–297.
Pandori M, Hobson D, Sano T . Adenovirus-microbead conjugates possess enhanced infectivity: a new strategy for localized gene delivery. Virology 2002; 299: 204–212.
Croyle MA, Cheng X, Wilson JM . Development of formulations that enhance physical stability of viral vectors for gene therapy. Gene Therapy 2001; 8: 1281–1290.
Schmitz JP, Hollinger JO . The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res 1986; 205: 299–308.
Friedmann T . Human gene therapy – an immature genie, but certainly out of the bottle. Nat Med 1996; 2: 144–147.
Franceschi RT, Wang D, Krebsbach PH, Rutherford RB . Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. J Cell Biochem 2000; 78: 476–486.
Schek RM, Hollister SJ, Krebsbach PH . Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy. Mol Ther 2004; 9: 130–138.
Alden TD, Pittman DD, Hankins GR, Beres EJ, Engh JA, Das S et al. In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector. Hum Gene Ther 1999; 10: 2245–2253.
Alden TD, Beres EJ, Laurent JS, Engh JA, Das S, London SD et al. The use of bone morphogenetic protein gene therapy in craniofacial bone repair. J Craniofac Surg 2000; 11: 24–30.
Alden TD, Pittman DD, Beres EJ, Hankins GR, Kallmes DF, Wisotsky BM et al. Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy. J Neurosurg 1999; 90: 109–114.
Lindsey WH . Osseous tissue engineering with gene therapy for facial bone reconstruction. Laryngoscope 2001; 111: 1128–1136.
Murakami P, McCaman MT . Quantitation of adenovirus DNA and virus particles with the PicoGreen fluorescent dye. Anal Biochem 1999; 274: 283–288.
Okubo Y, Bessho K, Fujimura K, Iizuka T, Miyatake SI . Osteoinduction by bone morphogenetic protein-2 via adenoviral vector under transient immunosuppression. Biochem Biophys Res Commun 2000; 267: 382–387.
Li JZ, Hankins GR, Kao C, Li H, Kammauff J, Helm GA . Osteogenesis in rats induced by a novel recombinant helper-dependent bone morphogenetic protein-9 (BMP-9) adenovirus. J Gene Med 2003; 5: 748–756.
Davidson BL, Hilfinger JM, Beer SJ . Extended release of adenovirus from polymer microspheres: potential use in gene therapy for brain tumors. Adv Drug Deliv Rev 1997; 27: 59–66.
Schreiber RE, Blease K, Ambrosio A, Amburn E, Sosnowski B, Sampath TK . Bone induction by AdBMP-2/collagen implants. J Bone Joint Surg Am 2005; 87: 1059–1068.
Tseng WC, Haselton FR, Giorgio TD . Transfection by cationic liposomes using simultaneous single cell measurements of plasmid delivery and transgene expression. J Biol Chem 1997; 272: 25641–25647.
Varga CM, Hong K, Lauffenburger DA . Quantitative analysis of synthetic gene delivery vector design properties. Mol Ther 2001; 4: 438–446.
Boontheekul T, Mooney DJ . Protein-based signaling systems in tissue engineering. Curr Opin Biotechnol 2003; 14: 559–565.
Vogel G . Gene therapy. FDA moves against Penn scientist. Science 2000; 290: 2049–2051.
Bengali Z, Shea LD . Gene delivery by immobilization to cell-adhesive substrates. Mrs Bull 2005; 30: 659–662.
Langer R . New methods of drug delivery. Science 1990; 249: 1527–1533.
Breen A, Strappe P, Kumar A, O'Brien T, Pandit A . Optimization of a fibrin scaffold for sustained release of an adenoviral gene vector. J Biomed Mater Res A 2006; 78: 702–708.
Bellocq NC, Kang DW, Wang X, Jensen GS, Pun SH, Schluep T et al. Synthetic biocompatible cyclodextrin-based constructs for local gene delivery to improve cutaneous wound healing. Bioconjug Chem 2004; 15: 1201–1211.
Bielinska AU, Yen A, Wu HL, Zahos KM, Sun R, Weiner ND et al. Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo. Biomaterials 2000; 21: 877–887.
Shen H, Tan J, Saltzman WM . Surface-mediated gene transfer from nanocomposites of controlled texture. Nat Mater 2004; 3: 569–574.
Luo D, Saltzman WM . Enhancement of transfection by physical concentration of DNA at the cell surface. Nat Biotechnol 2000; 18: 893–895.
Bengali Z, Pannier AK, Segura T, Anderson BC, Jang JH, Mustoe TA et al. Gene delivery through cell culture substrate adsorbed DNA complexes. Biotechnol Bioeng 2005; 90: 290–302.
Gambaro K, Aberdam E, Virolle T, Aberdam D, Rouleau M . BMP-4 induces a Smad-dependent apoptotic cell death of mouse embryonic stem cell-derived neural precursors. Cell Death Differ 2006; 13: 1075–1087.
Wang Y, Xue SA, Hallden G, Francis J, Yuan M, Griffin BE et al. Virus-associated RNA I-deleted adenovirus, a potential oncolytic agent targeting EBV-associated tumors. Cancer Res 2005; 65: 1523–1531.
Pikal MJ, Dellerman K, Roy ML . Formulation and stability of freeze-dried proteins: effects of moisture and oxygen on the stability of freeze-dried formulations of human growth hormone. Dev Biol Stand 1992; 74: 21–37; discussion 37–28.
Towns JK . Moisture content in proteins: its effects and measurement. J Chromatogr A 1995; 705: 115–127.
Jiang S, Nail SL . Effect of process conditions on recovery of protein activity after freezing and freeze-drying. Eur J Pharm Biopharm 1998; 45: 249–257.
Pristoupil TI, Kramlova M, Fortova H, Ulrych S . Haemoglobin lyophilized with sucrose: the effect of residual moisture on storage. Haematologia (Budapest) 1985; 18: 45–52.
Yang S, Wei D, Wang D, Phimphilai M, Krebsbach PH, Franceschi RT . In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J Bone Miner Res 2003; 18: 705–715.
Acknowledgements
The research is supported by AO Foundation (16-2004). The authors thank Dr Renny T Franceschi for providing the viral vector and Colleen L Flanagan for μ-CT technique assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hu, WW., Wang, Z., Hollister, S. et al. Localized viral vector delivery to enhance in situ regenerative gene therapy. Gene Ther 14, 891–901 (2007). https://doi.org/10.1038/sj.gt.3302940
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3302940
Keywords
This article is cited by
-
Recent advances in the development of gene delivery systems
Biomaterials Research (2019)
-
Biomaterial-guided delivery of gene vectors for targeted articular cartilage repair
Nature Reviews Rheumatology (2019)
-
Cationic lipid-nanoceria hybrids, a novel nonviral vector-mediated gene delivery into mammalian cells: investigation of the cellular uptake mechanism
Scientific Reports (2016)
-
Engineering Biomaterial Systems to Enhance Viral Vector Gene Delivery
Molecular Therapy (2011)
-
Surface immobilization of hexa-histidine-tagged adeno-associated viral vectors for localized gene delivery
Gene Therapy (2010)